RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders
Glia · 2023-03 · 71 (3) · 485-508
DOI: 10.1002/glia.24288 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Glia, online erschienen am 15.11.2022. Verfasst von Abhishek Guha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Central Nervous System Diseases. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 259 Literaturangaben. Gefördert von: U.S. Department of Veterans Affairs, Technology Transfer Program, NIH, Dept. of Veterans Affairs, University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Neuro-oncology Research Acceleration.
Abstract (Originalsprache)
A major hallmark of neuroinflammation is the activation of microglia and astrocytes with the induction of inflammatory mediators such as IL‐1β, TNF‐α, iNOS, and IL‐6. Neuroinflammation contributes to disease progression in a plethora of neurological disorders ranging from acute CNS trauma to chronic neurodegenerative disease. Posttranscriptional pathways of mRNA stability and translational efficiency are major drivers for the expression of these inflammatory mediators. A common element in this level of regulation centers around the adenine‐ and uridine‐rich element (ARE) which is present in the 3′ untranslated region (UTR) of the mRNAs encoding these inflammatory mediators. (ARE)‐binding proteins (AUBPs) such as Human antigen R (HuR), Tristetraprolin (TTP) and KH‐ type splicing regulatory protein (KSRP) are key nodes for directing these posttranscriptional pathways and either promote (HuR) or suppress (TTP and KSRP) glial production of inflammatory mediators. This review will discuss basic concepts of ARE‐mediated RNA regulation and its impact on glial‐driven neuroinflammatory diseases. We will discuss strategies to target this novel level of gene regulation for therapeutic effect and review exciting preliminary studies that underscore its potential for treating neurological disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department Cell, Developmental, and Integrative Biology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Birmingham Department of Veterans Health Care System, Birmingham, Alabama, USA.
- Center for Neurodegeneration and Experimental Therapeutics, The University of Alabama at Birmingham, Birmingham, USA.
ORCID-Profile: Abhishek Guha, Natalia Filippova, Peter H King
Förderung
- U.S. Department of Veterans Affairs, Technology Transfer Program, NIH
- Dept. of Veterans Affairs
- University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Neuro-oncology Research Acceleration
- NCI NIH HHS
- U.S. Department of Veterans Affairs
- National Cancer Institute
Zitieren
APA
Guha, A., Husain, M. A., Si, Y., Nabors, L. B., Filippova, N., Promer, G., Smith, R., & King, P. H. (2023). RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders. Glia, 71(3), 485-508. https://doi.org/10.1002/glia.24288
Vancouver
Guha A, Husain MA, Si Y, Nabors LB, Filippova N, Promer G, et al. RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders. Glia. 2023;71(3):485-508. doi:10.1002/glia.24288
BibTeX
@article{Guha2023,
author = {Guha, Abhishek and Husain, Mohammed Amir and Si, Ying and Nabors, L Burt and Filippova, Natalia and Promer, Grace and Smith, Reed and King, Peter H},
title = {RNA regulation of inflammatory responses in glia and its potential as a therapeutic target in central nervous system disorders},
journal = {Glia},
year = {2023},
volume = {71},
number = {3},
pages = {485--508},
doi = {10.1002/glia.24288}
}
EUVIMED